XML 146 R129.htm IDEA: XBRL DOCUMENT v3.24.0.1
Quarterly Financial Data (Unaudited) - Summary of Restatement of Certain Line Items in the Balance Sheets (Detail) - USD ($)
$ in Millions
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Quarterly Financial Information [Line Items]                  
Deferred income taxes $ 1,812 $ 1,755 $ 1,583 $ 1,577 $ 1,458 $ 1,546 $ 1,595    
Total assets 43,479 42,095 43,100 43,461 44,011 44,252 45,932    
Other taxes and long-term liabilities 4,019 3,950 4,094 3,982 3,945 3,859 3,860    
Total long-term liabilities 23,106 23,314 23,664 24,546 23,944 23,213 25,125    
Total liabilities 35,353 34,708 35,508 34,957 35,413 34,747 36,121    
Teva shareholders' equity:                  
Accumulated deficit (13,534) (13,995) (14,066) (13,194) (12,975) (11,673) (11,734)    
Total equity 8,126 7,387 7,592 8,504 8,598 9,506 9,810 $ 11,244 $ 11,061
Total liabilities and equity $ 43,479 42,095 43,100 43,461 44,011 44,252 45,932    
As previously reported [Member]                  
Quarterly Financial Information [Line Items]                  
Deferred income taxes   1,748 1,578 1,572 1,453 1,546 1,595    
Total assets   42,088 43,095 43,456 44,006 44,252 45,932    
Other taxes and long-term liabilities   3,818 3,973 3,869 3,847 3,846 3,842    
Total long-term liabilities   23,182 23,543 24,433 23,846 23,200 25,107    
Total liabilities   34,576 35,387 34,844 35,315 34,734 36,103    
Teva shareholders' equity:                  
Accumulated deficit   (13,870) (13,950) (13,086) (12,882) (11,660) (11,716)    
Total equity   7,512 7,708 8,612 8,691 9,519 9,828    
Total liabilities and equity   42,088 43,095 43,456 44,006 44,252 45,932    
Adjustment [Member]                  
Quarterly Financial Information [Line Items]                  
Deferred income taxes   7 5 5 5        
Total assets   7 5 5 5        
Other taxes and long-term liabilities   132 121 113 98 13 18    
Total long-term liabilities   132 121 113 98 13 18    
Total liabilities   132 121 113 98 13 18    
Teva shareholders' equity:                  
Accumulated deficit   (125) (116) (108) (93) (13) (18)    
Total equity   (125) (116) (108) (93) (13) (18)    
Total liabilities and equity   $ 7 $ 5 $ 5 $ 5 $ 0 $ 0